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Trummer et al Perioperative ManagementCA1, which showed signs of apoptosis. We conclude that
a certain amount of brain damage still occurs, although to
a limited extent, permitting recovery and survival. We
plan to investigate this issue, which was not examined in
this study, in our future research.
Study limitations include the use of juvenile animals and
their potentially better neurological recovery. Beyond that,
systemic heparinization for CPB was applied before CA
induction, but our dosages were much lower (300 IU/kg)
than the large dose (700 IU/kg)25 that improved survival
and neurological recovery whereby only 2 dogs were normal
and 4 of 6 were arousable. Furthermore, volatile anesthetics
can limit ischemic cerebral injury.26 Our model would be
more readily comparable with routine patients with CA if
the same experiments were conducted in lightly sedated an-
imals without administering heparin, muscle relaxants, iso-
flurane, and mechanical ventilation. However, we did not
get approval from the regulatory authorities for animal re-
search to use lightly sedated animals.
In conclusion, we present data showing 100% survival of
pigs after 15 minutes of normothermic CA and clinically ap-
parent neurological recovery in 6 of 7. This is in contrast to
current treatment methods, with which resuscitation is only
successful after CA times of 3 to 5 minutes, followed by fre-
quent neurological damage in the few survivors. This far bet-
ter survival and neurological outcome after prolonged
cardiac standstill is possible by treating the tissues damaged
previously by ischemia (CA) before normal blood reperfu-
sion is reinstituted. This new treatment consists of a modified
reperfusate and controlled conditions of reperfusion for the
initial 60 minutes using peripheral extracorporeal circula-
tion. We thus provide evidence that challenges the usual
100% mortality after 15 minutes of normothermic CA. If
our experimental results are confirmed by others in future
studies, resuscitation with CPB might evolve as a powerful
new tool in patients with sudden CA.P
MReferences
1. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P,
et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology.
Eur Heart J. 2001;22:1374-450.
2. Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time-sen-
sitive model. JAMA. 2002;288:3035-8.
3. Schultz SC, Cullinane DC, Pasquale MD, Magnant C, Evans SR. Predicting in-
hospital mortality during cardiopulmonary resuscitation. Resuscitation. 1996;
33:13-7.
4. Rea TD, Pearce RM, Raghunathan TE, Lemaitre RN, Sotoodehnia N, Jouven X,
et al. Incidence of out-of-hospital cardiac arrest. Am J Cardiol. 2004;93:
1455-60.
5. Fredriksson M, Herlitz J, Engdahl J. Nineteen years’ experience of out-of-hospital
cardiac arrest in Gothenburg—reported in Utstein style. Resuscitation. 2003;58:
37-47.
6. El Menyar AA. The resuscitation outcome: revisit the story of the stony heart.
Chest. 2005;128:2835-46.
7. Allen BS, Okamoto F, Buckberg GD, Bugyi H, Young H, Leaf J, et al. Immediate
functional recovery after six hours of regional ischemia by careful control of con-
ditions of reperfusion and composition of reperfusate. J Thorac Cardiovasc Surg.
1986;92:621-35.The Journal of Thoracic and Car8. Beyersdorf F, Kirsh M, Buckberg GD, Allen BS. Warm glutamate/aspartate-
enriched blood cardioplegic solution for perioperative sudden death. J Thorac
Cardiovasc Surg. 1992;104:1141-7.
9. Buckberg GD. When is cardiac muscle damaged irreversibly? J Thorac Cardio-
vasc Surg. 1986;92:483-7.
10. Buckberg GD. Strategies and logic of cardioplegic delivery to prevent, avoid, and
reverse ischemic and reperfusion damage. J Thorac Cardiovasc Surg. 1987;93:
127-39.
11. Halldorsson AO, Kronon M, Allen BS, Rahman S, Wang T, Layland M, et al.
Controlled reperfusion prevents pulmonary injury after 24 hours of lung preserva-
tion. Ann Thorac Surg. 1998;66:877-84.
12. Haab F, Julia P, Nochy D, Cambillau M, Fabiani JN, Thibault P. Improvement of
postischemic renal function by limitation of initial reperfusion pressure. J Urol.
1996;155:1089-93.
13. Beyersdorf F, Schlensak C. Controlled reperfusion after acute and persistent limb
ischemia. Semin Vasc Surg. 2009;22:52-7.
14. Rogove HJ, Safar P, Sutton-Tyrrell K, Abramson NS. Old age does not negate
good cerebral outcome after cardiopulmonary resuscitation: analyses from the
brain resuscitation clinical trials. The Brain Resuscitation Clinical Trial I and II
Study Groups. Crit Care Med. 1995;23:18-25.
15. Madl C, Holzer M. Brain function after resuscitation from cardiac arrest. Curr
Opin Crit Care. 2004;10:213-7.
16. Safar P, Abramson NS, Angelos M, Cantadore R, Leonov Y, Levine R, et al.
Emergency cardiopulmonary bypass for resuscitation from prolonged cardiac
arrest. Am J Emerg Med. 1990;8:55-67.
17. Sung K, Lee YT, Park PW, Park KH, Jun TG, Yang JH, et al. Improved survival
after cardiac arrest using emergent autopriming percutaneous cardiopulmonary
support. Ann Thorac Surg. 2006;82:651-6.
18. Levine R, Gorayeb M, Safar P, Abramson N, Stezoski W, Kelsey S. Cardiopul-
monary bypass after cardiac arrest and prolonged closed-chest CPR in dogs.
Ann Emerg Med. 1987;16:620-7.
19. Pretto E, Safar P, Saito R, Stezoski W, Kelsey S. Cardiopulmonary bypass after
prolonged cardiac arrest in dogs. Ann Emerg Med. 1987;16:611-9.
20. Boldyrev A, Song R, Dyatlov VA, Lawrence DA, Carpenter DO. Neuronal cell
death and reactive oxygen species. Cell Mol Neurobiol. 2000;20:433-50.
21. Beyersdorf F, Unger A, Wildhirt A, Kretzer U, Deutschlander N, Krueger S, et al.
Studies of reperfusion injury in skeletal muscle: preserved cellular viability after
extended periods of warm ischemia. J Cardiovasc Surg (Torino). 1991;32:664-76.
22. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;
357:1121-35.
23. Allen BS, Veluz JS, Buckberg GD, Aeberhard E, Ignarro LJ. Deep hypothermic
circulatory arrest and global reperfusion injury: avoidance by making a pump
prime reperfusate—a new concept. J Thorac Cardiovasc Surg. 2003;125:625-32.
24. Allen BS, Castella M, Buckberg GD, Tan Z. Conditioned blood reperfusion mark-
edly enhances neurologic recovery after prolonged cerebral ischemia. J Thorac
Cardiovasc Surg. 2003;126:1851-8.
25. Ichinose K, Okamoto T, Tanimoto H, Taguchi H, Tashiro M, Sugita M, et al. A
moderate dose of propofol and rapidly induced mild hypothermia with extracor-
poreal lung and heart assist (ECLHA) improve the neurological outcome after pro-
longed cardiac arrest in dogs. Resuscitation. 2006;70:275-84.
26. Kawaguchi M, Furuya H, Patel PM. Neuroprotective effects of anesthetic agents.
J Anesth. 2005;19:150-6.Discussion
Dr Ani Anyanwu (New York, NY). I have nothing to disclose.
This study is unique, and its authors are to be commended be-
cause they demonstrated survival with relatively preserved neuro-
logical recovery after 15 minutes of normothermic CA. Your
study differs from prior studies of resuscitative CPB by applying
controlled reperfusion, the theory being that subjecting the ische-
mic body cells to normotensive normal blood reperfusion as in con-
ventional CPB might be deleterious and result in secondary injury.
There are, however, several components to your intervention
that could explain the results.
This leads to the first of my 3 questions. You necessarily hepa-
rinized your animals before CA, presumably to allow cannulation
of vessels in preparation for later perfusion. To what degree dodiovascular Surgery c Volume 139, Number 5 1331
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Myou think heparinization could have contributed to your results?
Did you consider an alternative study design in which the animals
were heparinized and swiftly cannulated after CA?
Dr Trummer. Thank you very much for those very good
questions.
We expected this problem in our study, and we heparinized only
300 U/kg BW. The control group was heparinized at the same time,
and the animals in the control group died. Therefore we do not
really see a big effect on the heparin.
On the other hand, with the knowledge we have from those ex-
periments right now, we also would assume it is possible to place
the catheters without administering heparin, but then you might
have the risk of losing more animals in the treatment group because
of clotting. However, it should be possible just to start the pump
only with heparin and not administer heparin before.
Dr Anyanwu. Obviously in a clinical situation you could not
heparinize before arrest.
This takes me to the issue of the control group, which you men-
tioned. Your control group consisted of animals undergoing con-
ventional CPR after prolonged normothermic arrest, a condition
that we know from previous studies is not survivable. This was ex-
pectedly demonstrated in your results. I would argue therefore that
your control group was wasted and somewhat irrelevant. The pre-
ferred control group would have been animals undergoing conven-
tional hypothermic CPB after prolonged arrest. In that way we
could separate the effect of the controlled reperfusion from that
of CPB. This leads to my second question: What was the basis
for your choice of control group for this experiment?
Dr Trummer. Thank you very much for this comment. We per-
formed many pilot studies before this study. In those pilot studies
we performed CPR after 15 minutes of arrest and then started the
animals on bypass. Primarily in this group, 35% of the animals
died, and the subsequent 65%, or two thirds of them, had to
undergo bypass because they deteriorated with circulation.
We thought that would not be the right group to compare
because we hypothesized that conventional CPR reflects an uncon-
trolled reperfusion. Therefore, we chose animals with conventional
CPR as control group.
Dr Anyanwu. It then becomes difficult to isolate the effects of
controlled reperfusion.
Finally, being a clinician, I am interested in how I can extrapo-
late these findings to my clinical practice. It is impractical to expect
that we can use CPB to resuscitate all patients undergoing cardiopul-
monary arrest. Nevertheless, assuming you repeated these experi-
ments with conventional bypass controls and showed the same
results, there would be 2 things that I would choose to take back to
my practice from your study. First, when patients have CA intraoper-
atively or in the intensive care unit requiring emergency CPB, then
perfusion, once established, should first use a specified reperfusate
and be maintained at a low pressure for the first few minutes. Second
is that when I subject the heart or brain to ischemia, as in cardioplegic
arrest, heart transplantation, or cerebral circulatory arrest, I should al-
ways use some form of controlled reperfusion to re-establish perfu-
sion. Do you think these are valid extrapolations? Have you
changed your own practice in any way as a result of your study?
Dr Trummer. Thank you very much for this comment. That is
a thing of the future, and that is completely correct. Before we can
go out to the field, we have to do it within the hospital, within the1332 The Journal of Thoracic and Cardiovascular Suroperating room or the intensive care unit; that is where we have to
start it if we want to establish this new method of reperfusion. We
cannot go out and eradicate CPR in the field; that is not possible
right now, but it is one of the visions we have.
DrAnyanwu. I am asking the following: if I have a patient in the
operating room who has a CA, should I use a similar technique to
resuscitate them today?
Dr Trummer. From the results we have right now, it should be
possible to do it. We just did it now in animals but have not done it
in patients yet. Once we have more results, then we would go to the
ethical committee to prove that within clinical practice.
DrRichardJ. Shemin (LosAngeles,Calif). I have no disclosures.
This was a very interesting study, but the details of CPB are key to
understanding exactly what is going on here. Obviously, these pigs
look big, but I am sure they are juvenile pigs, and therefore the first
question is this: Do you think that there is some aspect between the
maturity of the animal and the potential recovery with this technique?
Dr Trummer. Thank you very much for this comment. That is
a potential limitation we discussed because these are juvenile pigs,
and those are around 50 to 60 kg. However, that is a moveable size
because the pigs have to stand up later on; if they are too big, they
cannot stand up anymore. That is one thing how to conduct the ex-
periment.
On the other hand, we needed a lot of things in the pump to get to
this point, a low perfusion pressure and low flow. We implemented
leukocyte filters; we were running them on pH stat, cooling them
down. Therefore there were a lot of things that I was unable to pres-
ent right now because we would go over the time.
Dr Shemin. So low pressure and low flow?
Dr Trummer. Low pressure, low flow, leukocyte filters in there,
cooling down and leaving the animals in pH stat immediately to
leave the cell in an acidotic environment to stop the metabolism
in there. That was the goal we wanted to achieve.
Dr Shemin. So what temperatures did you cool to?
Dr Trummer. We cooled them down immediately to 30C,
which we reached about 10 minutes after we started the pump.
Dr Shemin. One of the key aspects in your control group is that
all the animals failed to achieve hemodynamic stability and died,
and therefore you do not know anything about neurological recov-
ery in that group.
Dr Trummer. However, as I mentioned before, we did some ex-
periments at the University of California, Los Angeles, in which we
saw that the animals really came out poorly after conventional
CPR, irrespective of whether we started them later on bypass. If
the animals do not get out of VF, mortality is 100%.
Dr Shemin. The other aspect, and my final question, regards the
effect of the anesthetic. Obviously both groups received it, but ob-
viously to induce fibrillation during anesthesia actually probably
has some protective effect also.
Dr Trummer. That is completely correct. And we also tried to
get to this point, but right now it is not possible to conduct this ex-
periment on an awake animal. We took electroencephalograms
from the animals in previous studies and tried to keep the animal
as awake as possible looking to the electroencephalograms. There-
fore we save on anesthesia to avoid the protective effects, but that is
the only thing we can do right now.
Dr Shemin. What anesthetic agent did you use?
Dr Trummer. Isoflurane, low dose, and propofol.gery c May 2010
